A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)

Background: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Arti Gupta, S Sathiyanarayanan, Rajeev Aravindakshan, Rakesh Kakkar
Formato:	article
Lenguaje:	EN
Publicado:	Wolters Kluwer Medknow Publications 2021
Materias:	cardiovascular diseases checklist diabetes mellitus dietary noncommunicable disease obesity risk factors tobacco waist circumference Medicine R
Acceso en línea:	https://doaj.org/article/56550079204449be85408931ed2156e3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:56550079204449be85408931ed2156e3
record_format	dspace
spelling	oai:doaj.org-article:56550079204449be85408931ed2156e32021-11-12T10:11:33ZA pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)2008-78022008-821310.4103/ijpvm.IJPVM_206_19https://doaj.org/article/56550079204449be85408931ed2156e32021-01-01T00:00:00Zhttp://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2021;volume=12;issue=1;spage=134;epage=134;aulast=Guptahttps://doaj.org/toc/2008-7802https://doaj.org/toc/2008-8213Background: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based, validated, good quality, cost appropriate, and sustainable risk assessment score for NCD for developing countries like India. Methods: This descriptive retrospective study of diabetic camp data of 84 patients was conducted. A risk score having 10 questions and three measurements for NCDs appropriate for Indian communities was generated. It was compared to IDRS, FINDRISC, FRS, CBAC, and WHO/ISH prediction charts. Results: The study finally included 36 patients with NCD as case and 44 subjects without NCD as control. The means of weight, waist circumference, blood pressure, and blood sugar were significantly different among the two groups. AMNRAS of more than 14 was highly predictive for an individual to be at risk of NCD or sub clinical case of NCD requiring evaluation. The proposed cut-off of 8 for AMNRAS, the sensitivity and NPV was highest compared to other score, 88.9% and 84.6%, respectively. Score for the Area under curve was significantly higher for AMNRAS [0.83 (0.74 to 0.92)] compared to other scores. Conclusions: AMNRAS has higher performance parameters than the other five tested in the present study. Other scoring system performs only modestly in discrimination of NCD cases. The accuracy of AMNRAS for NCD risk will have to be determined in large size cohorts.Arti GuptaS SathiyanarayananRajeev AravindakshanRakesh KakkarWolters Kluwer Medknow Publicationsarticle cardiovascular diseaseschecklistdiabetes mellitusdietarynoncommunicable diseaseobesityrisk factorstobaccowaist circumference MedicineRENInternational Journal of Preventive Medicine, Vol 12, Iss 1, Pp 134-134 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	cardiovascular diseases checklist diabetes mellitus dietary noncommunicable disease obesity risk factors tobacco waist circumference Medicine R
spellingShingle	cardiovascular diseases checklist diabetes mellitus dietary noncommunicable disease obesity risk factors tobacco waist circumference Medicine R Arti Gupta S Sathiyanarayanan Rajeev Aravindakshan Rakesh Kakkar A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)
description	Background: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based, validated, good quality, cost appropriate, and sustainable risk assessment score for NCD for developing countries like India. Methods: This descriptive retrospective study of diabetic camp data of 84 patients was conducted. A risk score having 10 questions and three measurements for NCDs appropriate for Indian communities was generated. It was compared to IDRS, FINDRISC, FRS, CBAC, and WHO/ISH prediction charts. Results: The study finally included 36 patients with NCD as case and 44 subjects without NCD as control. The means of weight, waist circumference, blood pressure, and blood sugar were significantly different among the two groups. AMNRAS of more than 14 was highly predictive for an individual to be at risk of NCD or sub clinical case of NCD requiring evaluation. The proposed cut-off of 8 for AMNRAS, the sensitivity and NPV was highest compared to other score, 88.9% and 84.6%, respectively. Score for the Area under curve was significantly higher for AMNRAS [0.83 (0.74 to 0.92)] compared to other scores. Conclusions: AMNRAS has higher performance parameters than the other five tested in the present study. Other scoring system performs only modestly in discrimination of NCD cases. The accuracy of AMNRAS for NCD risk will have to be determined in large size cohorts.
format	article
author	Arti Gupta S Sathiyanarayanan Rajeev Aravindakshan Rakesh Kakkar
author_facet	Arti Gupta S Sathiyanarayanan Rajeev Aravindakshan Rakesh Kakkar
author_sort	Arti Gupta
title	A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)
title_short	A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)
title_full	A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)
title_fullStr	A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)
title_full_unstemmed	A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)
title_sort	pilot retrospective study validating noncommunicable disease risk assessment score (amnras)
publisher	Wolters Kluwer Medknow Publications
publishDate	2021
url	https://doaj.org/article/56550079204449be85408931ed2156e3
work_keys_str_mv	AT artigupta apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT ssathiyanarayanan apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rajeevaravindakshan apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rakeshkakkar apilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT artigupta pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT ssathiyanarayanan pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rajeevaravindakshan pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras AT rakeshkakkar pilotretrospectivestudyvalidatingnoncommunicablediseaseriskassessmentscoreamnras
_version_	1718430989359775744

A pilot retrospective study validating noncommunicable disease risk assessment score (AMNRAS)

Ejemplares similares